Precision for Medicine Webinars and Videos
-
Breaking Barriers With PCR: Innovative Solutions For Clinical Trial Success
9/3/2025
This presentation brings together experts from Precision for Medicine, Avidity Biosciences, and Indaptus Therapeutics to examine the expanding role of PCR-based molecular monitoring.
-
Beyond The Data Deluge: Immune Profiling In Early Immuno-Oncology Trials
8/14/2025
This presentation explores how to design effective immune monitoring for early-phase immuno-oncology trials, focusing on strategic platform selection, cost, and operational feasibility.
-
The 3 FDA Oncology Approvals That Will Have The Biggest Impact In 2025
7/25/2025
The FDA wrapped up 2024 with 3 notable approvals. Harpreet Singh, MD and CMO, provides a recap.
-
The FDA's New Guidance May Be Shaking Up Biotech
7/25/2025
The FDA’s recent draft guidance on accelerated approval outlines tougher standards for confirmatory trials and introduces a faster process for withdrawing approvals.
-
Precision In, Precision Out: Elevated Kitting Strategies For Clinical Trials
6/17/2025
As biomarker-driven clinical trials become increasingly complex, the design and management of clinical trial kits play a pivotal role in ensuring operational success and scientific integrity.
-
Achieving Regulatory Compliance With A Unified Immunogenicity Strategy
5/10/2025
This presentation equips viewers with the knowledge and tools needed to navigate the intricacies of designing immunogenicity assays that comply with both European IVDR and US FDA regulations.
-
Future-Proofing Gene Therapy Assays: Validation Strategies For Long-Term Success
5/10/2025
In this presentation, viewers engaged in early assay development or optimizing assays for later-phase trials will benefit from expert insight into the development of gene therapy immunogenicity assays.
-
Illuminating IHC: Right-Sizing Your Validation And Regulatory Strategy
5/2/2025
In this presentation, expert speakers provide an in-depth exploration of the essential validation and regulatory strategies for Immunohistochemistry (IHC).
-
Key Success Factors In Conducting A Translational Clinical Study
5/2/2025
As precision medicine and biomarker-driven trials become central to clinical development, managing the clinical sample lifecycle has never been more critical.